Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)

52 mg Through New Patient Commitment Program Eligible Patients May Obtain A Second LILETTA At No Out-Of-Pocket Cost for the Product DUBLIN, March 3, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc, (AGN) a leading global pharmaceutica... Biopharmaceuticals, Drug Delivery, Product LaunchAllergan, LILETTA, levonorgestrel, intrauterine system
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news